| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Akoya Biosciences (NASDAQ:AKYA) reported its Q4 earnings results on Monday, March 4, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Akoya Biosciences beat estimated earnings by 19.0%, reporting an EPS of $-0.22 versus an estimate of $-0.27.
Revenue was up $5.27 million from the same period last year.
Last quarter the company beat on EPS by $0.11 which was followed by a 11.0% increase in the share price the next day.
Here's a look at Akoya Biosciences's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.37 | -0.44 | -0.48 | -0.43 |
| EPS Actual | -0.26 | -0.51 | -0.49 | -0.50 |
| Revenue Estimate | 24.54M | 22.17M | 20.32M | 20.58M |
| Revenue Actual | 25.21M | 23.52M | 21.41M | 21.22M |
To track all earnings releases for Akoya Biosciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: AKYA
